Anza Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Anza Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus (NCT00800007) | Anza Therapeutics, Inc. | 2008-11-01 |
| Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment (NCT00585845) | Anza Therapeutics, Inc. | 2007-12-01 |
| Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases (NCT00327652) | Anza Therapeutics, Inc. | 2006-10-01 |
Track Anza Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.